SCOLR, Inc. ~ $10,400,000 Common Stocks and Warrants ~
February 2004
SCOLR, Inc. is a
biopharmaceutical company with proprietary, patented
technologies and products operating in the drug delivery and
nutraceuticals markets. After leading a successful offering of
$5.3 million of convertible notes last year, Taglich was
positioned to help Rodman & Renshaw execute this transaction of
common stock with warrants. Together, these two offerings
provide SCOLR with the necessary capital to fully develop and
commercialize its Controlled Delivery Technology CDT™. Being
able to help clients throughout their growth cycles, is just
another example of our commitment and support.
The information
contained herein does not constitute a solicitation of any order
to buy or sell any securities. The information provided herein
may be displayed and printed for your personal, noncommercial
use only. You may not reproduce, retransmit, distribute,
disseminate, sell, publish, broadcast or circulate the
information to anyone, without the express written consent of
Taglich Brothers, Inc.
